Controlled Correspondence Related to Generic Drug Development; Draft Guidance for Industry; Availability; Correction

---
identifier: "/us/fr/2017-24948"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Controlled Correspondence Related to Generic Drug Development; Draft Guidance for Industry; Availability; Correction"
title_number: 0
title_name: "Federal Register"
section_number: "2017-24948"
section_name: "Controlled Correspondence Related to Generic Drug Development; Draft Guidance for Industry; Availability; Correction"
positive_law: false
currency: "2017-11-17"
last_updated: "2017-11-17"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "2017-24948"
document_type: "notice"
publication_date: "2017-11-17"
agencies:
  - "Health and Human Services Department"
  - "Food and Drug Administration"
fr_citation: "82 FR 54386"
fr_volume: 82
docket_ids:
  - "Docket No. FDA-2014-D-1167"
fr_action: "Notice; correction."
---


#  Controlled Correspondence Related to Generic Drug Development; Draft Guidance for Industry; Availability; Correction

**AGENCY:**

Food and Drug Administration, HHS.

**ACTION:**

Notice; correction.

**SUMMARY:**

The Food and Drug Administration is correcting a notice entitled “Controlled Correspondence Related to Generic Drug Development; Draft Guidance for Industry; Availability” that appeared in the *Federal Register* of November 3, 2017. The document announced the availability of a draft guidance for industry. The document was published with the incorrect docket number. This document corrects that error.

**FOR FURTHER INFORMATION CONTACT:**

Lisa Granger, Office of Policy, Food and Drug Administration, 10903 New Hampshire Ave. Bldg. 32, Rm. 3330, Silver Spring, MD 20993-0002, 301-796-9115, *[email protected].*

**SUPPLEMENTARY INFORMATION:**

In the *Federal Register* of Friday, November 3, 2017 (82 FR 51277), in FR Doc. 2017-23947, the following correction is made:

On page 51277, in the second column, in the header of the document, “[Docket FDA-2014-D-1147]” is corrected to read “[Docket No. FDA-2014-D-1167]”.

Dated: November 9, 2017.

Anna K. Abram,

Deputy Commissioner for Policy, Planning, Legislation, and Analysis.